RESUMEN
Prehabilitation has a multimodal conception based on three fundamental pillars: improvement of the patient's physical condition, nutritional optimization and cognitive intervention to reduce stress and anxiety, as well as other measures such as smoking cessation and correction of anemia. The aim of prehabilitation programs is to optimize the patient from the moment of diagnosis until the surgical intervention in order to reduce postoperative complications. As in the case of multimodal rehabilitation protocols, the actions of prehabilitation programs have synergistic effects, that is, small changes that, by themselves, do not have clinical significance but when added up, they produce a significant improvement in the postoperative evolution of patients. Although more studies are required to evaluate the impact of these programs on patients groups with different pathologies, interventions and risk factors, their progressive implementation is necessary in the daily clinical practice of our patients. The objective of this narrative review is to evaluate the available evidence about prehabilitation in surgery, focusing on current established strategies, knowledge gaps and future research.
Asunto(s)
Recuperación Mejorada Después de la Cirugía , Complicaciones Posoperatorias/prevención & control , Ejercicio Preoperatorio/fisiología , Anemia/terapia , Ansiedad/prevención & control , Composición Corporal , Capacidad Cardiovascular/fisiología , Ejercicio Físico , Humanos , Conciliación de Medicamentos , Atención Plena , Estado Nutricional , Acondicionamiento Físico Humano , Rendimiento Físico Funcional , Pruebas Psicológicas , Cese del Hábito de Fumar , Estrés Fisiológico/fisiología , Prueba de PasoRESUMEN
Simultaneous presentation of breast cancer and malignant phyllodes tumour is rare. A female patient presented with a nodule in her left breast (infiltrating ductal carcinoma). On magnetic nuclear resonance another suspicious lesion (malignant phyllodes) was found in the right breast. Bilateral mastectomy was performed. Thirty two months later the patient is still free of disease. The approach to dealing with synchronous breast tumours should be the same as that normally used.